Mandate

Vinge Advises Tech Data on the Acquisition of Scribona Assets

March 11, 2008

Vinge represents Tech Data in connection to the acquisition of Scribona’s assets in Sweden, Finland and Norway. The business deal, which was made official on March the 4th, is conditioned by the approval of Scribona’s shareholders, which annual general meeting will take place on the 29th of April, but also by the approval of the competition authority of the European Union.   

Tech Data is listed on NASDAQ and it is one of the world’s largest distributors of Information Technology, it has an estimated revenue of USD 23 billion. Scribona is listed on Small Cap on OMX Nordic Exchange and one of Sweden, Finland and Norway’s leading distributors of Information Technology products. Scribona’s revenue has an approximate value of SEK 8 billions. Tech Data will, by the acquisition, become the largest distributor of Information Technology in the Nordic countries.

Partners Ulf Sallnäs (M&A), Fredrik Dahl (Employment) and Johan Karlsson (Antitrust) joined by associates Martin Hall (M&A), Emma Olsson (Employment) as well as Peter Alstergren and economist Mattias Ganslandt (Antitrust) made up Vinge’s team.      

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026